Insulet launches algorithm improvements for Omnipod 5 AID system in US
Insulet has begun distributing an updated version of its Omnipod 5 automated insulin delivery (AID) system across the US, following…
All articles by Salong Debbarma
Salong Debbarma
-
-
J&J’s nipocalimab meets primary endpoint in Phase II JASMINE study
Johnson & Johnson (J&J) has reported that its monoclonal antibody, nipocalimab, met the primary endpoint in the Phase II JASMINE…
-
Regeneron and CytomX extend cancer therapy partnership to $4bn deal
Regeneron Pharmaceuticals and CytomX have expanded their research and licensing partnership to develop conditionally activated bispecific antibody cancer therapies, with…
-
Moonlight begins SURVEYOR Phase I trial for peanut allergy
Moonlight Therapeutics has begun the SURVEYOR Phase I clinical trial to assess MOON101, an investigational immunotherapy for peanut allergy. The…
-
Roche’s giredestrant secures FDA priority review for breast cancer
The US Food and Drug Administration (FDA) has accepted priority review of the new drug application (NDA) for Roche’s investigational…
-
Philips secures FDA clearance for Elevate Plus AI ultrasound upgrade
Philips has received the US Food and Drug Administration (FDA) 510(k) clearance for Elevate Plus, an upgrade that adds new…
-
Jade reports interim Phase I results of JADE101 for IgAN
Jade Biosciences has reported positive interim data from its Phase I trial studying JADE101, an investigational anti-A proliferation-inducing ligand (APRIL)…
-
MicroPort launches LBBOT Solution commercially in Europe and Australia
MicroPort CardioFlow has commercially launched its LBBOT Solution in Europe and Australia after obtaining the required regulatory approvals. The LBBOT…
-
Servier to acquire Edgewise’s muscular dystrophy business for $2.65bn
Servier has signed an agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in a deal valued at up to $2.65bn.…
-
SKIA secures FDA 510(k) clearance for AR surgical platform
South Korean medical technology company SKIA has received the US Food and Drug Administration (FDA) 510(k) clearance for SKIA HEAD,…